4.6 Review

Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine

Journal

ACS BIOMATERIALS SCIENCE & ENGINEERING
Volume 8, Issue 7, Pages 2764-2797

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.2c000942764

Keywords

bioprinting; 3D-printed technology; 4D printing technology; microfluidics

Funding

  1. Australian Government Research Training Program
  2. NHMRC [2002723]

Ask authors/readers for more resources

This review explores the potential and applications of 3D printing and 3D bioprinting in healthcare, including the production of personalized products, patient-specific tissues, and organ-on-chip constructs. It also discusses how tailoring parameters and adopting dynamic 4D printing strategies can optimize and overcome limitations of conventional 3D printing technologies.
Three-dimensional (3D) printing and 3D bioprinting are promising technologies for a broad range of healthcare applications from frontier regenerative medicine and tissue engineering therapies to pharmaceutical advancements yet must overcome the challenges of biocompatibility and resolution. Through comparison of traditional biofabrication methods with 3D (bio)printing, this review highlights the promise of 3D printing for the production of on-demand, personalized, and complex products that enhance the accessibility, effectiveness, and safety of drug therapies and delivery systems. In addition, this review describes the capacity of 3D bioprinting to fabricate patient-specific tissues and living cell systems (e.g., vascular networks, organs, muscles, and skeletal systems) as well as its applications in the delivery of cells and genes, microfluidics, and organ-on-chip constructs. This review summarizes how tailoring selected parameters (i.e., accurately selecting the appropriate printing method, materials, and printing parameters based on the desired application and behavior) can better facilitate the development of optimized 3D-printed products and how dynamic 4D-printed strategies (printing materials designed to change with time or stimulus) may be deployed to overcome many of the inherent limitations of conventional 3D-printed technologies. Comprehensive insights into a critical perspective of the future of 4D bioprinting, crucial requirements for 4D printing including the programmability of a material, multimaterial printing methods, and precise designs for meticulous transformations or even clinical applications are also given.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available